On Thursday 07/18/2024 the closing price of the The Cigna Group Registered Shs share was $340.66 on BTT.
Compared to the opening price on Thursday 07/18/2024 on BTT of $342.14, this is a drop of 0.43%.
The Cigna Group Registered Shs's market capitalization is $95.46 B by 284.07 M shares outstanding.
Is The Cigna Group Registered Shs stock a Buy, Sell or Hold?
The Cigna Group Registered Shs stock has received a consensus rating of buy. The average rating score is and is based on 44 buy ratings, 25 hold ratings, and 0 sell ratings.What was the 52-week low for The Cigna Group Registered Shs stock?
The low in the last 52 weeks of The Cigna Group Registered Shs stock was 253.97. According to the current price, The Cigna Group Registered Shs is 132.32% away from the 52-week low.What was the 52-week high for The Cigna Group Registered Shs stock?
The high in the last 52 weeks of The Cigna Group Registered Shs stock was 365.71. According to the current price, The Cigna Group Registered Shs is 91.89% away from the 52-week high.What are analysts forecasts for The Cigna Group Registered Shs stock?
The 69 analysts offering price forecasts for The Cigna Group Registered Shs have a median target of 350.17, with a high estimate of 435.00 and a low estimate of 253.00. The median estimate represents a 95.97 difference from the last price of 336.05.The Cigna Group Registered Stock Snapshot
324.94
Bid
100.00
Bid Size
347.99
Ask
1.00
Ask Size
7/19/2024
Date
3:59 PM
Time
0.00
Volume
340.66
Prev. Close
0.00
Open
284.07 M
Number of Shares
253.97
52 Week Low
365.71
52 Week High
336.05
4.92
Dividend in USD
1.64
Dividend Yield
17.22
P/E Ratio
98.13
Free Float in %
17.57
EPS in USD
158.03
Book Value per Share in USD
39.79
Cash Flow per Share in USD
The Cigna Group Registered Shs News More News
Historical Prices for The Cigna Group Registered Shs
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:
0%
0
The Cigna Group Registered Shs Analyst Data
Total Analysts: 69
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 253.00
Median: 350.17
Highest: 435.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
The Cigna Group Registered Shs Analyst Opinions
- All
- Buy
- Hold
- Sell
| Date | Analyst | Rating | Price | |||
|---|---|---|---|---|---|---|
| 07/10/24 | Cantor Fitzgerald | Maintained Buy | $400 | |||
| 06/26/24 | Piper Sandler | Maintained Buy | $400 | |||
| 06/12/24 | Cantor Fitzgerald | Maintained Buy | $400 | |||
| 05/30/24 | J.P. Morgan | Maintained Buy | $435 | |||
| 05/30/24 | Baird Patrick & Co | Maintained Buy | $388 | |||
| 05/03/24 | Cantor Fitzgerald | Maintained Buy | $400 | |||
| 05/03/24 | Oppenheimer & Co. Inc. | Maintained Buy | $400 | |||
| 04/10/24 | Cantor Fitzgerald | Maintained Buy | $384 | |||
| 03/08/24 | Cantor Fitzgerald | Maintained Buy | $384 | |||
| 03/08/24 | UBS | Maintained Buy | $400 | |||
| 03/08/24 | RBC Capital Markets | Maintained Buy | $383 | |||
| 03/08/24 | Mizuho | Maintained Buy | $385 | |||
| 03/06/24 | Barclays Capital | Maintained Buy | $393 | |||
| 03/04/24 | Morgan Stanley | Maintained Buy | $392 | |||
| 03/04/24 | Cantor Fitzgerald | Maintained Buy | $372 | |||
| 02/06/24 | Wells Fargo & Co | Maintained Hold | $348 | |||
| 02/05/24 | Mizuho | Maintained Buy | $370 | |||
| 02/05/24 | RBC Capital Markets | Upgraded to Buy | $354 | |||
| 02/05/24 | Cantor Fitzgerald | Upgraded to Buy | $372 | |||
| 02/01/24 | Deutsche Bank | Upgraded to Buy | $370 | |||
| 01/19/24 | Cantor Fitzgerald | Maintained Hold | $334 | |||
| 01/17/24 | Oppenheimer & Co. Inc. | Maintained Buy | $360 | |||
| 01/04/24 | Bernstein | Upgraded to Buy | $372 | |||
| 12/12/23 | Deutsche Bank | Maintained Hold | $355 | |||
| 12/11/23 | Jefferies & Company Inc. | Upgraded to Buy | $341 | |||
| 11/30/23 | RBC Capital Markets | Maintained Hold | $327 | |||
| 11/15/23 | RBC Capital Markets | Maintained Hold | $327 | |||
| 11/03/23 | RBC Capital Markets | Maintained Hold | $327 | |||
| 11/03/23 | Cantor Fitzgerald | Maintained Hold | $334 | |||
| 09/14/23 | Cantor Fitzgerald | Maintained Hold | $310 | |||
| 08/18/23 | Edward Jones | Downgraded to Hold | ||||
| 08/07/23 | Raymond James Financial, Inc. | Maintained Buy | $330 | |||
| 08/04/23 | Bank of America Merrill Lynch | Maintained Buy | $350 | |||
| 07/13/23 | UBS | Maintained Buy | $355 | |||
| 07/07/23 | J.P. Morgan | Maintained Buy | $341 | |||
| 06/28/23 | Stephens Inc. | Maintained Buy | $345 | |||
| 06/06/23 | Bank of America Merrill Lynch | Upgraded to Buy | $320 | |||
| 05/08/23 | Deutsche Bank | Maintained Hold | $310 | |||
| 05/08/23 | RBC Capital Markets | Maintained Hold | $287 | |||
| 05/08/23 | Wells Fargo & Co | Maintained Hold | $284 | |||
| 05/08/23 | Raymond James Financial, Inc. | Maintained Buy | $310 | |||
| 04/26/23 | Bernstein | Maintained Hold | $253 | |||
| 04/21/23 | Cantor Fitzgerald | Maintained Hold | $285 | |||
| 04/05/23 | Raymond James Financial, Inc. | Upgraded to Buy | $350 | |||
| 03/30/23 | Mizuho | Maintained Buy | $360 | |||
| 03/21/23 | Stephens Inc. | Maintained Buy | $370 | |||
| 02/28/23 | Stephens Inc. | Maintained Buy | $370 | |||
| 02/23/23 | J.P. Morgan | Maintained Buy | $370 | |||
| 02/08/23 | SVB Leerink | Maintained Hold | $335 | |||
| 02/07/23 | Raymond James Financial, Inc. | Maintained Buy | $350 |
The Cigna Group Registered Shs Estimates* in USD
| 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|
| Revenue | 235,569 | 245,776 | 261,142 | 268,594 | 284,777 |
| Dividend | 6.69 | 6.84 | 7.25 | - | - |
| Dividend Yield (in %) | 1.99 % | 2.03 % | 2.16 % | - | - |
| EPS | 28.50 | 31.97 | 35.86 | 39.61 | 42.90 |
| P/E Ratio | 11.79 | 10.51 | 9.37 | 8.48 | 7.83 |
| EBIT | 9,494 | 10,705 | 11,403 | 12,078 | 12,811 |
| EBITDA | 13,024 | 14,025 | 15,038 | 15,286 | - |
| Net Profit | 8,086 | 8,672 | 9,300 | 8,845 | 9,761 |
| Net Profit Adjusted | 8,086 | 8,672 | 9,300 | 9,338 | 9,761 |
| Pre-Tax Profit | 10,226 | 9,469 | 11,977 | - | 10,912 |
| Net Profit (Adjusted) | 6,419 | 9,192 | 9,968 | 10,456 | 10,912 |
| EPS (Non-GAAP) ex. SOE | 28.50 | 31.97 | 35.86 | 39.61 | 42.90 |
| EPS (GAAP) | 18.52 | 26.52 | 29.94 | 34.23 | 37.66 |
| Gross Income | 21,059 | 21,937 | 23,415 | - | - |
| Cash Flow from Investing | -7,074 | -9,415 | -8,797 | -8,589 | -9,392 |
| Cash Flow from Operations | 19,284 | 11,738 | 12,280 | 12,175 | 13,161 |
| Cash Flow from Financing | -7,074 | -9,415 | -8,797 | -8,589 | -9,392 |
| Cash Flow per Share | 37.79 | 41.86 | 44.61 | - | - |
| Free Cash Flow | 11,150 | 10,466 | 10,349 | 10,332 | - |
| Free Cash Flow per Share | - | - | - | - | - |
| Book Value per Share | 151.17 | 161.42 | 200.62 | - | - |
| Net Debt | 20,875 | 15,517 | 7,803 | 17,494 | 16,750 |
| Research & Development Exp. | - | - | - | - | - |
| Capital Expenditure | 1,425 | 1,455 | 1,586 | 2,063 | 3,025 |
| Selling, General & Admin. Exp. | 14,270 | 14,385 | 15,116 | 16,339 | 16,630 |
| Shareholder’s Equity | 42,452 | 42,859 | 47,490 | 37,841 | 36,305 |
| Total Assets | 166,851 | 169,086 | 173,714 | 162,751 | 179,949 |
|
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | 22 | 22 | 22 | 22 | 22 |
| Average Estimate | 6.431 USD | 7.773 USD | 7.861 USD | 28.500 USD | 31.965 USD |
| Year Ago | 4.957 USD | 4.788 USD | 3.518 USD | 17.571 USD | - |
| Publish Date | 8/1/2024 | 10/31/2024 | 1/31/2025 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | 14 | 14 | 14 | 19 | 17 |
| Average Estimate | 58,298 USD | 58,954 USD | 61,027 USD | 235,569 USD | 245,776 USD |
| Year Ago | 48,612 USD | 49,034 USD | 51,080 USD | 195,187 USD | - |
| Publish Date | 8/1/2024 | 10/31/2024 | 1/31/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales | 195,187.00 | 180,021.00 | 174,274.00 | 160,550.00 | 153,743.00 | 48,569.00 | 41,616.00 |
| Change of sales in % | 8.42 | 3.30 | 8.55 | 4.43 | 216.55 | 16.71 | 4.91 |
| Gross profit on sales | - | - | - | - | - | - | - |
| Gross profit on sales change in % | - | - | - | - | - | - | - |
| Operating income | 8,956.00 | 8,048.00 | 8,441.00 | 8,784.00 | 9,064.00 | 4,852.00 | 4,182.00 |
| Operating income change in % | 11.28 | -4.66 | -3.90 | -3.09 | 86.81 | 16.02 | 31.30 |
| Income before tax | 5,513.00 | 8,353.00 | 6,782.00 | 10,868.00 | 6,570.00 | 3,581.00 | 3,606.00 |
| Income before tax change in % | -34.00 | 23.16 | -37.60 | 65.42 | 83.47 | -0.69 | 21.05 |
| Income after tax | 5,164.00 | 6,668.00 | 5,365.00 | 8,458.00 | 5,104.00 | 2,637.00 | 2,237.00 |
| Income after tax change in % | -22.56 | 24.29 | -36.57 | 65.71 | 93.55 | 17.88 | 19.82 |
Balance Sheet in Mio. USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Total liabilities | 101,575.00 | 94,957.00 | 103,840.00 | 100,399.00 | 105,840.00 | 107,328.00 | 41,969.00 |
| Long-term liabilities per share | - | - | - | - | - | - | - |
| Equity | 46,351.00 | 44,951.00 | 47,184.00 | 50,386.00 | 45,379.00 | 41,072.00 | 13,784.00 |
| Equity change in % | 3.01 | -4.75 | -6.38 | 10.99 | 10.51 | 198.71 | 0.09 |
| Balance sheet total | 147,926.00 | 139,908.00 | 151,024.00 | 150,785.00 | 151,219.00 | 148,400.00 | 55,753.00 |
| Balance sheet total change in % | 5.73 | -7.36 | 0.16 | -0.29 | 1.90 | 166.17 | 5.06 |
Key Data in USD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Sales per share | 657.46 | 575.03 | 511.12 | 435.82 | 404.78 | 194.10 | 163.15 |
| P/E ratio (year end quote, basic EPS) | 17.22 | 15.56 | 14.59 | 9.07 | 15.22 | 18.02 | 23.16 |
| P/E ratio (year end quote, diluted EPS) | 17.22 | 15.56 | 14.59 | 9.07 | 15.22 | 18.02 | 23.16 |
| P/E ratio (year end quote) | 17.22 | 15.56 | 14.59 | 9.07 | 15.22 | 18.02 | 23.16 |
| Dividend yield in % | 1.64 | 1.35 | 1.74 | 0.02 | 0.02 | 0.02 | 0.02 |
| Equity ratio in % | 31.25 | 32.07 | 31.20 | 33.37 | 29.98 | 27.65 | 24.64 |
| Debt ratio in % | 68.67 | 67.87 | 68.76 | 66.58 | 69.99 | 72.32 | 75.28 |
The Cigna Group Registered Shs Insider Activity
| Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
|---|---|---|---|---|---|---|
| Evanko Brian C | 06/24/2024 | 1,011.00 | 40,934.00 | 120.90 | Buy | No |
| Evanko Brian C | 06/23/2024 | 4,795.00 | 39,923.00 | 345.01 | Sell | No |
| Evanko Brian C | 06/23/2024 | 4,795.00 | 44,718.00 | 120.90 | Buy | No |
| Granger Elder | 06/16/2024 | 547.00 | 5,471.00 | 331.38 | Sell | No |
| Granger Elder | 06/16/2024 | 547.00 | 6,018.00 | 175.09 | Buy | No |
| Granger Elder | 06/11/2024 | 1,000.00 | 5,471.00 | 338.08 | Sell | No |
| Granger Elder | 06/11/2024 | 1,000.00 | 6,471.00 | 175.09 | Buy | No |
| Eder Noelle K | 05/14/2024 | 875.00 | 16,699.00 | 171.39 | Buy | No |
| Eder Noelle K | 05/13/2024 | 10,700.00 | 15,824.00 | 348.47 | Sell | No |
| Agoglia Hoeltzel Mary T | 05/13/2024 | 5,946.00 | 2,594.74 | 348.71 | Sell | No |
| Eder Noelle K | 05/13/2024 | 5,533.00 | 26,524.00 | 171.39 | Buy | No |
| Agoglia Hoeltzel Mary T | 05/13/2024 | 5,946.00 | 8,540.74 | 120.90 | Buy | No |
| Hathi Neesha | 04/23/2024 | 539.00 | 2,731.00 | n/a | Buy | No |
| WISEMAN ERIC C | 04/23/2024 | 539.00 | 22,520.00 | n/a | Buy | No |
| DeLaney William J III | 04/23/2024 | 539.00 | 17,539.00 | n/a | Buy | No |
| Ozuah Phillip | 04/23/2024 | 539.00 | 1,163.00 | n/a | Buy | No |
| Ross Kimberly A. | 04/23/2024 | 539.00 | 3,874.00 | n/a | Buy | No |
| Granger Elder | 04/23/2024 | 539.00 | 5,471.00 | n/a | Buy | No |
| FOSS ERIC J | 04/23/2024 | 539.00 | 35,276.00 | n/a | Buy | No |
| Kurian George | 04/23/2024 | 539.00 | 3,140.00 | n/a | Buy | No |
| McClellan Mark B. | 04/23/2024 | 539.00 | 5,471.00 | n/a | Buy | No |
| MAZZARELLA KATHLEEN M | 04/23/2024 | 539.00 | 5,471.00 | n/a | Buy | No |
| ZARCONE DONNA F | 04/23/2024 | 539.00 | 26,097.00 | n/a | Buy | No |
| Cordani David | 03/25/2024 | 7,761.00 | 355,815.00 | 139.22 | Buy | No |
| Cordani David | 03/24/2024 | 31,209.00 | 348,054.00 | 355.17 | Sell | No |
The Cigna Group Registered Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2023 | The Cigna Group Registered Shs | 4.92 | 1.64 | USD |
| 2022 | The Cigna Group Registered Shs | 4.48 | 1.35 | USD |
| 2021 | The Cigna Group Registered Shs | 4.00 | 1.74 | USD |
| 2020 | The Cigna Group Registered Shs | 0.04 | 0.02 | USD |
| 2019 | The Cigna Group Registered Shs | 0.04 | 0.02 | USD |
| 2018 | The Cigna Group Registered Shs | 0.04 | 0.02 | USD |
| 2017 | The Cigna Group Registered Shs | 0.04 | 0.02 | USD |
| 2016 | The Cigna Group Registered Shs | 0.04 | 0.03 | USD |
| 2015 | The Cigna Group Registered Shs | 0.04 | 0.03 | USD |
| 2014 | The Cigna Group Registered Shs | 0.04 | 0.04 | USD |
| 2013 | The Cigna Group Registered Shs | 0.04 | 0.05 | USD |
| 2012 | The Cigna Group Registered Shs | 0.04 | 0.07 | USD |
| 2011 | The Cigna Group Registered Shs | 0.04 | 0.10 | USD |
| 2010 | The Cigna Group Registered Shs | 0.04 | 0.11 | USD |
| 2009 | The Cigna Group Registered Shs | 0.04 | 0.11 | USD |
| 2008 | The Cigna Group Registered Shs | 0.04 | 0.24 | USD |
| 2007 | The Cigna Group Registered Shs | 0.04 | 0.07 | USD |
| 2006 | The Cigna Group Registered Shs | 0.03 | 0.07 | USD |
| 2005 | The Cigna Group Registered Shs | 0.03 | 0.08 | USD |
| 2004 | The Cigna Group Registered Shs | 0.14 | 0.51 | USD |
| 2003 | The Cigna Group Registered Shs | 0.44 | 2.30 | USD |
| 2002 | The Cigna Group Registered Shs | 0.44 | 3.21 | USD |
| 2001 | The Cigna Group Registered Shs | 0.43 | 1.39 | USD |
| 2000 | The Cigna Group Registered Shs | 0.41 | 0.93 | USD |
| 1999 | The Cigna Group Registered Shs | 0.40 | 1.49 | USD |
*Yield of the Respective Date
The Cigna Group Registered Shs Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Press Conference | - | 08/01/2024 | |
| Earnings Report | 6.431 USD | Q2 2024 Earnings Release | 08/01/2024 |
| Earnings Report | 7.773 USD | Q3 2024 Earnings Release | 10/31/2024 |
| Earnings Report | 7.861 USD | Q4 2024 Earnings Release | 01/31/2025 |
| Earnings Report | 6.957 USD | Q1 2025 Earnings Release | 05/01/2025 |
| Earnings Report | 7.573 USD | Q2 2025 Earnings Release | 07/31/2025 |
| Earnings Report | 8.644 USD | Q3 2025 Earnings Release | 10/30/2025 |
The Cigna Group Registered Shs Past Events
| Event | Actual EPS | Info | Date |
|---|---|---|---|
| Press Conference | - | - | 05/02/2024 |
| Annual General Meeting | - | Annual General Meeting | 04/24/2024 |
The Cigna Group Registered Shs Profile
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U. S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments.
Moody’s Daily Credit Risk Score
The Cigna Group Registered Shs Shareholder
| Owner | in % |
|---|---|
| Freefloat | 98.13 |
| Vanguard Group, Inc. (Subfiler) | 8.99 |
| The Vanguard Group, Inc. | 8.72 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 4.91 |
| State Street Corp. | 4.69 |
| Dodge & Cox | 4.62 |
| Massachusetts Financial Services Co. | 3.92 |
| Dodge & Cox Stock Fund | 3.25 |
| Vanguard Total Stock Market ETF | 3.16 |
| Fidelity Management & Research Co. LLC | 3.14 |
| Sanders Capital LLC | 2.74 |
| Vanguard 500 Index Fund | 2.57 |
| BlackRock Fund Advisors | 2.49 |
| BlackRock Institutional Trust Co. NA | 2.27 |
| Geode Capital Management LLC | 2.06 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
The Cigna Group Registered Shs Management
| Name | Job |
|---|---|
| Brian C. Evanko | CFO, President & CEO-Cigna Healthcare |
| David Michael Cordani | Chairman, President & Chief Executive Officer |
| Jamie Kates | Chief Accounting Officer |
| Nicole S. Jones | Chief Administrative Office, EVP & General Counsel |
| David J. Brailer | Chief Health Office & Executive Vice President |
| Everett Neville | Executive VP-Strategy & Business Development |
| Paul Sanford | Executive Vice President-Operations |
| Noelle K. Eder | Global Chief Information Officer & Executive VP |
| Neesha Hathi | Independent Director |
| Kathleen M. Mazzarella | Independent Director |
| Philip O. Ozuah | Independent Director |
| George Kurian | Independent Director |
| Eric J. Foss | Independent Director |
| Donna F. Zarcone | Independent Director |
| William J. DeLaney | Independent Director |
| Elder Granger | Independent Director |
| Kimberly A. Ross | Independent Director |
| Mark B. McClellan | Independent Director |
| Eric C. Wiseman | Lead Independent Director |
| Jason D. Sadler | President-International Markets |
| Chris DeRosa | President-United States Government |
| Kari Knight Stevens | Secretary, Chief Human Resources Officer & EVP |
| Ralph Giacobbe | Senior Vice President-Investor Relations |